A Novel Fluorescent Gemcitabine Prodrug That Follows a Nucleoside Transporter‐Independent Internalization and Bears Enhanced Therapeutic Efficacy With Respect to Gemcitabine.
Saved in:
| Title: | A Novel Fluorescent Gemcitabine Prodrug That Follows a Nucleoside Transporter‐Independent Internalization and Bears Enhanced Therapeutic Efficacy With Respect to Gemcitabine. |
|---|---|
| Authors: | Vrettos, Eirinaios Ι.1 (AUTHOR), Kyrkou, Stavroula G.1 (AUTHOR), Zoi, Vasiliki2 (AUTHOR), Giannakopoulou, Maria2 (AUTHOR), Chatziathanasiadou, Maria V.1 (AUTHOR), Kanaki, Zoi3 (AUTHOR), Agalou, Adamantia4 (AUTHOR), Bistas, Vasileios‐Panagiotis1 (AUTHOR), Kougioumtzi, Anastasia5 (AUTHOR), Karampelas, Theodoros4 (AUTHOR), Diamantis, Dimitrios A.1 (AUTHOR), Murphy, Carol5 (AUTHOR), Beis, Dimitris4,6 (AUTHOR), Klinakis, Apostolos3 (AUTHOR), Tamvakopoulos, Constantin4 (AUTHOR), Kyritsis, Athanasios P.2 (AUTHOR), Alexiou, George A.2 (AUTHOR), Tzakos, Andreas G.1 (AUTHOR) atzakos@uoi.gr |
| Source: | Chemistry - A European Journal. 9/5/2024, Vol. 30 Issue 50, p1-8. 8p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 09476539 |
|---|---|
| DOI: | 10.1002/chem.202401327 |
